Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal misoprostol versus isosorbide mononitrate versus control for cervical preparation in miscarriage under 20 weeks
IRCT20190901044658N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of misoprostol and isosorbide mononitrate in Pregnancy loss, stillbirth and birth defect (3 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoint: Cervical preparation. Started Jun 2019; status: completed.
02
Drugs
misoprostolisosorbide mononitrate
03
Conditions
Pregnancy lossstillbirthbirth defect
Beyond the preview
Go deeper on IRCT20190901044658N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190901044658N1.